Combination of HBIG and lamivudine-resistant mutations: a formula for trouble?

Liver Transpl. 2002 Nov;8(11):1082-4. doi: 10.1053/jlts.2002.36238.

Authors

Robert J Fontana¹, Anna S F Lok

Affiliation

¹ Division of Gastroenterology University of Michigan Medical School Ann Arbor, MI, USA.

PMID: 12424727
DOI: 10.1053/jlts.2002.36238

No abstract available

MeSH terms

DNA-Directed DNA Polymerase / genetics
Drug Resistance / genetics
Drug Therapy, Combination
Hepatitis B / drug therapy
Hepatitis B / virology
Hepatitis B virus / genetics
Hepatitis B virus / physiology*
Humans
Immunoglobulins / therapeutic use*
Lamivudine / adverse effects*
Lamivudine / therapeutic use*
Liver Transplantation
Mutation / physiology*
Postoperative Complications
Reverse Transcriptase Inhibitors / therapeutic use*
Virus Replication / drug effects

Substances

Immunoglobulins
Reverse Transcriptase Inhibitors
Lamivudine
DNA-Directed DNA Polymerase
hepatitis B hyperimmune globulin